Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics, Q2 2012

Sep 13 2012

• By Deanna Kamienski

Related Content

Astellas Experiments With Partnering Models For a Phase IIa Ulcerative Colitis Compound

Apr 27 2012

Third Rock Pumps $41 Million Into Global Blood Therapeutics

Jun 14 2012

Celgene Licenses Lead Program From Epizyme, Takes Option To Remaining Pipeline

Apr 26 2012

The Renal Denervation Buzz: Separating Fact From Myth; Covidien Buys Maya Medical

Jun 22 2012

Renal Denervation Sparks Device Market Gold Rush

May 25 2012

Related Companies

Tesaro, Inc.

Eisai Co., Ltd.

Opko Health

Amgen, Inc.

Merck & Co., Inc.

Clovis Oncology, Inc.

Fortress Biotech Inc.

OvaScience, Inc.

Harvard University

Harvard University

Rhythm Pharmaceuticals, Inc.

Ipsen SA

Miragen Therapeutics, Inc.

Global Blood Therapeutics, Inc.

Kona Medical, Inc.

Progyny, Inc.

Stanford University

Good Start Genetics, Inc.

VitaPath Genetics Inc.

Bristol Myers Squibb Company

Inhibrx, Inc.

Epizyme, Inc.

Merck & Co., Inc.

Astellas Pharma, Inc.

Drais Pharmaceuticals, Inc.

Drais Pharmaceuticals, Inc.

Drais Pharmaceuticals, Inc.

MetaStat Inc.

Yeshiva University

Albert Einstein College of Medicine

Ridge Diagnostics Inc.

Ameritox, Ltd.

Insight Genetics

NeoGenomics, Inc.

General Electric

General Electric

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

The University of Texas System

University of Texas MD Anderson Cancer Center

Bausch Health Companies Inc.

Onset Dermatologics LLC

Covidien plc

Additional Topics

Deals BioPharmaceutical Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window